Literature DB >> 26022569

Vaccines: from valuation to resource allocation.

David E Bloom1, Guruprasad Madhavan2.   

Abstract

This review focuses on selected challenges and opportunities concerning broader valuation of vaccines and immunization. The challenges involve conceptualizing and measuring the value of vaccines, while the opportunities relate to the strategic and systematic use of that information in health policy decisions that range from the adoption of particular vaccines in national immunization plans to the allocation of resources to vaccine research, development, and delivery. Clarifying the demonstrable individual, family, and community-level benefits of vaccines will allow the public health community to make better-informed and more meaningful comparisons of the costs of vaccines in relation to their full benefits. Taking advantage of this opportunity will require enhanced data collection and the development of strategic planning tools for transparently assessing trade-offs among the myriad attributes of different vaccines in various social and economic contexts.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  Data collection; Resource allocation; Strategic planning tools

Mesh:

Substances:

Year:  2015        PMID: 26022569     DOI: 10.1016/j.vaccine.2015.02.071

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Advancing sustainable development goals through immunization: a literature review.

Authors:  Catherine Decouttere; Kim De Boeck; Nico Vandaele
Journal:  Global Health       Date:  2021-08-26       Impact factor: 4.185

Review 2.  The full benefits of adult pneumococcal vaccination: A systematic review.

Authors:  Elizabeth T Cafiero-Fonseca; Andrew Stawasz; Sydney T Johnson; Reiko Sato; David E Bloom
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 3.  Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?

Authors:  Luis J Jara; Olga Vera-Lastra; Naim Mahroum; Carlos Pineda; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2022-04-05       Impact factor: 3.650

4.  Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.

Authors:  Sachiko Ozawa; Samantha Clark; Allison Portnoy; Simrun Grewal; Meghan L Stack; Anushua Sinha; Andrew Mirelman; Heather Franklin; Ingrid K Friberg; Yvonne Tam; Neff Walker; Andrew Clark; Matthew Ferrari; Chutima Suraratdecha; Steven Sweet; Sue J Goldie; Tini Garske; Michelle Li; Peter M Hansen; Hope L Johnson; Damian Walker
Journal:  Bull World Health Organ       Date:  2017-06-27       Impact factor: 9.408

5.  Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits.

Authors:  Andrew Stawasz; Liping Huang; Paige Kirby; David Bloom
Journal:  Front Public Health       Date:  2020-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.